Matching slides 18,554
Current window 2,461-2,490
Pages 619
Rows per page 30
Component: Quoteclear collectionreset all

Component

2,461-2,490 of 18,554

filter-aware
23
The slide uses direct quotes from an expert consultation to build a case for potential fraud or misrepresentation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment3 hits
44
The slide uses direct quotes from a neurologist to cast doubt on Bioprojet's professionalism and data management.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle3 hits
47
The slide uses direct quotes from two different medical professionals to highlight a pattern of disregard for safety protocols.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle3 hits
88
Uses expert quotes to establish a 'villain' (the drug class/mechanism) and preemptively rebut its efficacy.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
95
The slide uses expert testimony to establish a precedent of failure in the H3 receptor space, specifically contrasting J&J's robust trials with Bioprojet's pitolisant.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
98
The slide uses direct quotes from a J&J scientist to undermine the credibility of Bioprojet's research capabilities.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
99
The slide uses a combination of summary bullet points and direct quotes from a consultation call to discredit the competitor's scientific rigor.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
103
The slide presents two distinct expert critiques regarding IP expiration and clinical trial quality, attributed to a senior scientist at Johnson & Johnson.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
254
The slide uses direct quotes from a KOL to undermine the market potential of Wakix.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
259
The slide highlights a negative expert opinion on drug efficacy, contrasting it with the prescriber's own behavior.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
261
The slide presents qualitative feedback from a medical professional, highlighting skepticism and administrative barriers.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
266
The slide highlights the physician's self-proclaimed influence and his personal relationship with sales reps, potentially exposing aggressive marketing tactics.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
273
The slide uses a Q&A transcript format to validate the summary points provided at the top.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
275
The slide uses direct quotes from a consultation call to challenge the drug's safety and efficacy profile.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
276
The slide contrasts the prescriber's relaxed attitude toward cardiac/hepatic monitoring with a specific, concerning anecdote about a patient experiencing uncontrollable anger.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
290
The slide uses direct quotes from KOLs and specialists to undermine a specific company value proposition.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
292
The slide uses direct quotes to expose a contradiction between the company's marketing (non-controlled status) and the actual physician experience (high administrative burden).Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
326
The slide uses direct quotes from former territory managers to substantiate allegations of fraudulent marketing practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
333
The slide uses direct quotes to expose potential unethical or illegal marketing practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
334
The slide uses direct quotes from former territory managers to establish the 'unusual' nature of the compensation plan.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 3 hits
109
The slide uses a 'villain critique' approach by contrasting company marketing with internal expert skepticism.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 3 hits
112
The slide uses direct quotes from a quantum computing expert to undermine the reliability of the subject's technology.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Loop · Iceberg3 hits
113
The slide uses direct quotes from a quantum computing expert to undermine the reliability and performance claims of IonQ.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Loop · Iceberg3 hits
123
Uses the 'elves in the background' metaphor to suggest hidden manual labor.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 3 hits
127
The slide uses highlighted text to emphasize key critical points within the quotes.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 3 hits
129
The slide uses direct quotes from a former senior scientific employee to undermine the company's technical roadmap.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 3 hits
134
The slide uses direct quotes and highlights to undermine the company's claims of production-grade technology.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 3 hits
144
The slide uses a direct transcript excerpt to frame the CEO's refusal to provide transparency as a red flag.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Conclusion that IonQ's Claims are Exaggerated3 hits
152
The slide uses a direct quote from an earnings call transcript to expose a lack of transparency regarding revenue sources.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 3 hits
179
The slide uses screenshots of LinkedIn and interview transcripts to support the claim of a manufactured persona.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 3 hits